Suzhou Innomed Medical Device Co., Ltd. (Innomed) is an innovative technology enterprise engaged in the development and manufacturing of interventional and implantable medical devices. The company was established in January, 2013 with headquarter located in the BioBay complex of Suzhou Industrial Park in the Jiangsu Province of China. The headquarter has an ISO13485 certified manufacturing plant with on-site clean room.

Founders and senior management team of Innomed have extensive expertise ranging from medical device development and discovery, use of advanced implantable materials, product design and evaluation, manufacturing process optimization, quality, clinical, and regulatory implementation, and staff managing and development. The R&D team has profound experience and solid track records in early stage product development to product market launch in various interventional cardiovascular and peripheral devices including guidewires, unique implantable stents for SFA/POP, Venous, Quick Fenestrater, and various structural heart products to address the mitral valve repair.

Based upon these core competences, know how, and experiences, Innomed has built a unique IP landscape, families of coronary and peripheral guidewire product pipelines and unique braided self-expanding stent system product lines. Two coronary and peripheral families of guidewires have already completed registrations and received regulatory approval in both US and China. Several other unique design guidewires for TAVR and neuro applications are being under development and testing for regulatory approval. From the stent product line, the peripheral vascular stent system, Inno-Spring, which won the 2016 Red Dot Design Award, has entered the clinical studies. The venous stent system is ready to kick off the clinical studies.